Chemoinformaics analysis of Malvidin-3-Diglucoside
Molecular Weight | 655.582 | nRot | 9 |
Heavy Atom Molecular Weight | 620.302 | nRig | 29 |
Exact Molecular Weight | 655.187 | nRing | 5 |
Solubility: LogS | -1.91 | nHRing | 3 |
Solubility: LogP | -0.747 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 81 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 2 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 35 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
nHA | 16 | APOL | 85.4018 |
nHD | 10 | BPOL | 47.2642 |
QED | 0.118 |
Synth | 4.976 |
Natural Product Likeliness | 1.73 |
NR-PPAR-gamma | 0.933 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.99 |
HIA | 0.98 |
CACO-2 | -6.442 |
MDCK | 0.000107134 |
BBB | 0.449 |
PPB | 0.732958 |
VDSS | 0.648 |
FU | 0.339776 |
CYP1A2-inh | 0.005 |
CYP1A2-sub | 0.052 |
CYP2c19-inh | 0.003 |
CYP2c19-sub | 0.063 |
CYP2c9-inh | 0 |
CYP2c9-sub | 0.119 |
CYP2d6-inh | 0.001 |
CYP2d6-sub | 0.175 |
CYP3a4-inh | 0.002 |
CYP3a4-sub | 0.003 |
CL | 1.437 |
T12 | 0.672 |
hERG | 0.023 |
Ames | 0.479 |
ROA | 0.041 |
SkinSen | 0.022 |
Carcinogencity | 0.038 |
EI | 0.004 |
Respiratory | 0.021 |
NR-Aromatase | 0.896 |
Antiviral | Yes |
Prediction | 0.785738 |